PAHO Does Not Recommend Taking Products that Contain Chlorine Dioxide, Sodium Chlorite, Sodium Hypochlorite, or Derivatives, 16 July 2020

dc.date.accessioned	2020
dc.date.available	2020
dc.date.issued	2020
dc.identifier.govdoc	PAHO/IMS/PHE/COVID-19/20-0040
dc.identifier.uri	https://iris.paho.org/handle/10665.2/52515
dc.description.abstract	PAHO does not recommend oral or parenteral use of chlorine dioxide or sodium chlorite-based products for patients with suspected or diagnosed COVID-19 or for anyone else. There is no evidence of their effectiveness and the ingestion or inhalation of such products could cause serious adverse effects.	en_US
dc.language.iso	en	en_US
dc.publisher	PAHO	en_US
dc.rights	Attribution-NonCommercial-ShareAlike 3.0 IGO	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-sa/3.0/igo/	*
dc.subject	COVID-19	en_US
dc.subject	Coronavirus	en_US
dc.subject	Pandemics	en_US
dc.subject	Chlorine Dioxide	en_US
dc.title	PAHO Does Not Recommend Taking Products that Contain Chlorine Dioxide, Sodium Chlorite, Sodium Hypochlorite, or Derivatives, 16 July 2020	en_US
dc.type	Procedures, manuals, guidelines	en_US
dc.rights.holder	Pan American Health Organization	en_US
dc.contributor.corporatename	Pan American Health Organization	en_US
dc.description.notes	The information included in this note reflects the available evidence at the date of publication.	en_US
paho.isfeatured	0	en_US
paho.publisher.country	United States	en_US
paho.publisher.city	Washington, D.C.	en_US
paho.source.centercode	US1.1	en_US
paho.relation.languageVersion	10665.2/52484	en_US
paho.contributor.department	Evidence and Intelligence for Action in Health (EIH)	en_US
paho.iswhotranslation	No	en_US

This notice should be preserved along with the article's original URL.Attribution-NonCommercial-ShareAlike 3.0 IGO

Related items